UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000002022
Receipt No. R000002468
Scientific Title Phase I / II clinical trial of peptide vaccination therapy for unresectable / recurrent pancreatic cancer to be refractory to chemotherapy by using new tumor antigen KIF20A and A2402 restrictive epitope peptide of the VEGFR1 origin related gene of tumor vascularization
Date of disclosure of the study information 2009/05/31
Last modified on 2015/06/01 14:09:03

No. Disposal Last modified on Item of update
1 Insert 2009/05/31 23:23:35
2 Update 2009/09/07 15:51:14 Public title
3 Update 2009/09/07 15:52:43 Narrative objectives1
4 Update 2009/09/07 16:02:29 Interventions/Control_1
5 Update 2009/09/07 16:03:39 Recruitment status
6 Update 2009/12/21 15:38:24 Blinding
7 Update 2012/03/06 20:15:28 Last follow-up date
8 Update 2012/12/03 15:48:09 Post marketing survey by drug manufacture etc., specified by Japanese law.
9 Update 2012/12/03 15:49:15 Publication of results
10 Update 2015/06/01 14:08:23 Email
Last name of contact person
Last name of contact person
Email
11 Update 2015/06/01 14:09:03 Recruitment status


Contact us.